On May 11, 2020, Beroni Group is pleased to announce that its development of a medical solution using nanobody technology for the novel coronavirus (SARS-CoV-2), in collaboration with Tianjin University…
After official review, the Beroni’s SARS-CoV-2 IgG/IgM Antibody Detection Kit is confirmed to comply with the quality standards and safety requirements stated in the “Announcement on Further Strengthening the Quality…
On the morning of the last day of December in 2019, Beroni China held its 2019 Work Summary Meeting. Mr. Jacky Zhang, Executive Chairman of Beroni Group, senior management of…
On 7th December, the Third Precision Medicine & Medical Care and Aging International Forum (“Forum”) organized by the Silk-Road Industry and Finance International Alliance and Beroni Group Limited, and co-sponsored…
The finals of the Tianjin Xiqing District’s Golden Technology Innovation Project Competition was successfully held on the 20th of November 2019. This competition was jointly organized by Tianjin Xiqing District’s…
On 11 November, senior management of Beroni Group welcomed Mr. Jun Furukawa, CEO of Capital Medica Co.,Ltd. (Capital Medica), Mr. Samejima Tomohiro, CEO of KURACI Co.,Ltd. and Mr. Takahiro Shirono,…
On October 28, 2019, the signing ceremony for trilateral strategic cooperation framework (between Jiangdong Holding Group, Zhongjing Huahong and Beroni Group) was held in Nanhu Hotel, Maanshan City, Anhui Province.…
On 18th September 2019, the Silk-Road Industry and Finance International Alliance (SIFIA) awarded Beroni China the “Model Work Entity” of the Healthcare Professional Committee and recognized Mr. Jacky Zhang, Executive…
